Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atropine dose-ranging ocular effects study in adults with myopia
ACTRN12618000508279Phase 2Recruiting
- Sponsor
- University of New South Wales
- Start
- Aug 2018
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of atropine in myopia (4 arms), sponsored by University of New South Wales. Primary endpoint: Change in pupil size and responses. Started Aug 2018; status: recruiting.
02
Drugs
atropine
03
Conditions
myopia
Beyond the preview
Go deeper on ACTRN12618000508279.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12618000508279.